N. Teramoto et al., Properties and pharmacological modification of ATP-sensitive K+ channels in cat tracheal myocytes, BR J PHARM, 130(3), 2000, pp. 625-635
1 The effects of leveromakalim and nucleoside diphosphates (NDPs) on both m
embrane currents and unitary currents in cat trachea myocytes were investig
ated by use of patch-clamp techniques.
2 In conventional whole-cell configuration, leveromakalim produced a concen
tration-dependent K+ current which was suppressed by additional application
of 5 mu M glibenclamide at -70 mV. When 3 mM ATP was added in the pipette
solution, the peak amplitude of the leveromakalim-induced current was much
smaller than that in the absence of ATP.
3 When 3 mM uridine 5'-diphosphate (UDP) was included in the pipette soluti
on, much higher concentrations of glibendamide (greater than or equal to 50
mu M) were required to suppress the 100 mu M leveromakalim-induced membran
e current in comparison with those in the absence of UDP.
4 In the cell-attached patches, leveromakalim activated a 40 pS K+ channel
which was inhibited by additional application of glibenclamide in symmetric
al 140 mM K+ conditions.
5 UDP (greater than or equal to 0.1 mM) was capable of reactivating the cha
nnel in inside-out patches in which the glibenclamide-sensitive K+ channel
had run down, in the presence of leveromakalim. The K+ channel reactivated
by UDP was suppressed by additional application of either intracellular 3 m
M ATP or 100 mu M glibenclamide.
6 These results demonstrate that smooth muscle cells in the cat trachea pos
sess ATP-sensitive 40 pS K+ channels which are blocked by glibenclamide (i.
e. K-ATP) and can be activated by leveromakalim and that intracellular UDP
causes a significant shift of the glibenclamide-sensitivity of these channe
ls.